Table of Content

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Immunotherapy Drugs Market

4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
        4.3.4. Global Immunotherapy Drugs Market Analysis and Forecast, 2017–2031

5. Key Insights
    5.1. Pipeline Analysis
    5.2. Key Industry Events
    5.3. COVID-19 Impact Analysis

6. Global Immunotherapy Drugs Market Analysis and Forecast, by Drug Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Drug Type, 2017–2031
        6.3.1. Monoclonal Antibodies
        6.3.2. Immunomodulators
        6.3.3. Cell Therapy
        6.3.4. Others (Vaccines, etc.)
    6.4. Market Attractiveness Analysis, by Drug Type

7. Global Immunotherapy Drugs Market Analysis and Forecast, by Therapy Area
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Therapy Area, 2017–2031
        7.3.1. Cancer
        7.3.2. Autoimmune Diseases
        7.3.3. Infectious Diseases
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by Therapy Area

8. Global Immunotherapy Drugs Market Analysis and Forecast, by Distribution Channel
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by Distribution Channel, 2017–2031
        8.3.1. Retail Pharmacies
        8.3.2. Online Pharmacies
        8.3.3. Hospital Pharmacies

9. Global Immunotherapy Drugs Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region

10. North America Immunotherapy Drugs Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Drug Type, 2017–2031
        10.2.1. Monoclonal Antibodies
        10.2.2. Immunomodulators
        10.2.3. Cell Therapy
        10.2.4. Others (Vaccines, etc.)
    10.3. Market Value Forecast, by Therapy Area, 2017–2031
        10.3.1. Cancer
        10.3.2. Autoimmune Diseases
        10.3.3. Infectious Diseases
        10.3.4. Others
    10.4. Market Value Forecast, by Distribution Channel, 2017–2031
        10.4.1. Retail Pharmacies
        10.4.2. Online Pharmacies
        10.4.3. Hospital Pharmacies
    10.5. Market Attractiveness Analysis
        10.5.1. By Drug Type
        10.5.2. By Therapy Area
        10.5.3. By Distribution Channel
        10.5.4. By Country

11. Europe Immunotherapy Drugs Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Drug Type, 2017–2031
        11.2.1. Monoclonal Antibodies
        11.2.2. Immunomodulators
        11.2.3. Cell Therapy
        11.2.4. Others (Vaccines, etc.)
    11.3. Market Value Forecast, by Therapy Area, 2017–2031
        11.3.1. Cancer
        11.3.2. Autoimmune Diseases
        11.3.3. Infectious Diseases
        11.3.4. Others
    11.4. Market Value Forecast, by Distribution Channel, 2017–2031
        11.4.1. Retail Pharmacies
        11.4.2. Online Pharmacies
        11.4.3. Hospital Pharmacies
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Drug Type
        11.6.2. By Therapy Area
        11.6.3. By Distribution Channel
        11.6.4. By Country/Sub-region

12. Asia Pacific Immunotherapy Drugs Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Drug Type, 2017–2031
        12.2.1. Monoclonal Antibodies
        12.2.2. Immunomodulators
        12.2.3. Cell Therapy
        12.2.4. Others (Vaccines, etc.)
    12.3. Market Value Forecast, by Therapy Area, 2017–2031
        12.3.1. Cancer
        12.3.2. Autoimmune Diseases
        12.3.3. Infectious Diseases
        12.3.4. Others
    12.4. Market Value Forecast, by Distribution Channel, 2017–2031
        12.4.1. Retail Pharmacies
        12.4.2. Online Pharmacies
        12.4.3. Hospital Pharmacies
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Drug Type
        12.6.2. By Therapy Area
        12.6.3. By Distribution Channel
        12.6.4. By Country/Sub-region
13. Latin America Immunotherapy Drugs Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Drug Type, 2017–2031
        13.2.1. Monoclonal Antibodies
        13.2.2. Immunomodulators
        13.2.3. Cell Therapy
        13.2.4. Others (Vaccines, etc.)
    13.3. Market Value Forecast, by Therapy Area, 2017–2031
        13.3.1. Cancer
        13.3.2. Autoimmune Diseases
        13.3.3. Infectious Diseases
        13.3.4. Others
    13.4. Market Value Forecast, by Distribution Channel, 2017–2031
        13.4.1. Retail Pharmacies
        13.4.2. Online Pharmacies
        13.4.3. Hospital Pharmacies
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Drug Type
        13.6.2. By Therapy Area
        13.6.3. By Distribution Channel
        13.6.4. By Country/Sub-region
14. Middle East & Africa Immunotherapy Drugs Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Drug Type, 2017–2031
        14.2.1. Monoclonal Antibodies
        14.2.2. Immunomodulators
        14.2.3. Cell Therapy
        14.2.4. Others (Vaccines, etc.)
    14.3. Market Value Forecast, by Therapy Area, 2017–2031
        14.3.1. Cancer
        14.3.2. Autoimmune Diseases
        14.3.3. Infectious Diseases
        14.3.4. Others
    14.4. Market Value Forecast, by Distribution Channel, 2017–2031
        14.4.1. Retail Pharmacies
        14.4.2. Online Pharmacies
        14.4.3. Hospital Pharmacies
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Drug Type
        14.6.2. By Therapy Area
        14.6.3. By Distribution Channel
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Global Immunotherapy Drugs Market, Company Share Analysis (2022)
    15.2. Company Profiles
        15.2.1. Bristol Myers Squibb
            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.1.2. Product Portfolio
            15.2.1.3. Financial Overview
            15.2.1.4. SWOT Analysis
            15.2.1.5. Strategic Overview
        15.2.2. Merck KGaA, Inc.
            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.2.2. Product Portfolio
            15.2.2.3. Financial Overview
            15.2.2.4. SWOT Analysis
            15.2.2.5. Strategic Overview
        15.2.3. Novartis AG
            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.3.2. Product Portfolio
            15.2.3.3. Financial Overview
            15.2.3.4. SWOT Analysis
            15.2.3.5. Strategic Overview
        15.2.4. AstraZeneca
            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.4.2. Product Portfolio
            15.2.4.3. Financial Overview
            15.2.4.4. SWOT Analysis
            15.2.4.5. Strategic Overview
        15.2.5. Pfizer
            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.5.2. Product Portfolio
            15.2.5.3. Financial Overview
            15.2.5.4. SWOT Analysis
            15.2.5.5. Strategic Overview
        15.2.6. Amgen
            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.6.2. Product Portfolio
            15.2.6.3. Financial Overview
            15.2.6.4. SWOT Analysis
            15.2.6.5. Strategic Overview
        15.2.7. Gilead Sciences
            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.7.2. Product Portfolio
            15.2.7.3. Financial Overview
            15.2.7.4. SWOT Analysis
            15.2.7.5. Strategic Overview
        15.2.8. Regeneron Pharmaceuticals Inc.
            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.8.2. Product Portfolio
            15.2.8.3. Financial Overview
            15.2.8.4. SWOT Analysis
            15.2.8.5. Strategic Overview
        15.2.9. F. Hoffmann-La Roche AG
            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.9.2. Product Portfolio
            15.2.9.3. Financial Overview
            15.2.9.4. SWOT Analysis
            15.2.9.5. Strategic Overview
        15.2.10. Eli Lilly and Company
            15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.10.2. Product Portfolio
            15.2.10.3. Financial Overview
            15.2.10.4. SWOT Analysis
            15.2.10.5. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: Global Immunotherapy Drugs Market Value Share, by Region, 2022

Figure 03: Global Immunotherapy Drugs Market Value Share, by Drug Type, 2022

Figure 04: Global Immunotherapy Drugs Market Value Share, by Therapy Area, 2022

Figure 05: Global Immunotherapy Drugs Market Value Share, by Distribution Channel, 2022

Figure 06: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031

Figure 07: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2022

Figure 08: Global Immunotherapy Drugs Market Value Share Analysis, by Drug Type, 2031

Figure 09: Global Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031

Figure 10: Global Immunotherapy Drugs Market Value (US$ Mn), by Monoclonal Antibodies, 2017?2031

Figure 11: Global Immunotherapy Drugs Market Value Share Analysis, by Monoclonal Antibodies, 2022 and 2031

Figure 12: Global Immunotherapy Drugs Market Value (US$ Mn), by Immunomodulators, 2017?2031

Figure 13: Global Immunotherapy Drugs Market Value Share Analysis, by Immunomodulators, 2022 and 2031

Figure 14: Global Immunotherapy Drugs Market Value (US$ Mn), by Cell Therapy, 2017?2031

Figure 15: Global Immunotherapy Drugs Market Value Share Analysis, by Cell Therapy, 2022 and 2031

Figure 16: Global Immunotherapy Drugs Market Value (US$ Mn), by Others, 2017?2031

Figure 17: Global Immunotherapy Drugs Market Value Share Analysis, by Others, 2022 and 2031

Figure 18: Global Immunotherapy Drugs Market Value Share Analysis, by Therapy Area, 2022 and 2031

Figure 19: Global Immunotherapy Drugs Market Value Share Analysis, by Therapy Area, 2022

Figure 20: Global Immunotherapy Drugs Market Value Analysis, by Therapy Area, 2031

Figure 21: Global Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023–2031

Figure 22: Global Immunotherapy Drugs Market Value (US$ Mn), by Cancer, 2017?2031

Figure 23: Global Immunotherapy Drugs Market Value Share Analysis, by Cancer, 2022 and 2031

Figure 24: Global Immunotherapy Drugs Market Value (US$ Mn), by Autoimmune Diseases, 2017?2031

Figure 24: Global Immunotherapy Drugs Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031

Figure 25: Global Immunotherapy Drugs Market Value (US$ Mn), by Autoimmune Diseases, 2017?2031

Figure 25: Global Immunotherapy Drugs Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031

Figure 26: Global Immunotherapy Drugs Market Value (US$ Mn), by Others, 2017?2031

Figure 27: Global Immunotherapy Drugs Market Value Share Analysis, by Others, 2022 and 2031

Figure 28: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031

Figure 29: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2022

Figure 30: Global Immunotherapy Drugs Market Value Share Analysis, by Distribution Channel, 2031

Figure 31: Global Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 32: Global Immunotherapy Drugs Market Value (US$ Mn), by Retail Pharmacies, 2017?2031

Figure 33: Global Immunotherapy Drugs Market Value Share Analysis, by Retail Pharmacies, 2022 and 2031

Figure 34: Global Immunotherapy Drugs Market Value (US$ Mn), by Online Pharmacies, 2017?2031

Figure 35: Global Immunotherapy Drugs Market Value Share Analysis, by Online Pharmacies, 2022 and 2031

Figure 36: Global Immunotherapy Drugs Market Value (US$ Mn), by Hospital Pharmacies, 2017?2031

Figure 36: Global Immunotherapy Drugs Market Value Share Analysis, by Hospital Pharmacies, 2022 and 2031

Figure 37: Global Immunotherapy Drugs Market Value Share Analysis, by Region, 2022 and 2031

Figure 38: Global Immunotherapy Drugs Market Value Share Analysis, by Region, 2022

Figure 39: Global Immunotherapy Drugs Market Value Analysis, by Region, 2031

Figure 40: Global Immunotherapy Drugs Market Attractiveness Analysis, by Region, 2023–2031

Figure 41: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 42: North America Immunotherapy Drugs Market Value Share Analysis, by Country, 2022 and 2031

Figure 43: North America Immunotherapy Drugs Market Attractiveness Analysis, by Country, 2023–2031

Figure 44: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031

Figure 45: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022

Figure 46: North America Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031

Figure 47: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031

Figure 48: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022

Figure 49: North America Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023–2031

Figure 50: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031

Figure 51: North America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022

Figure 52: North America Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 53: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 54: Europe Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 55: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 56: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031

Figure 57: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022

Figure 58: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031

Figure 59: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031

Figure 60: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022

Figure 61: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023–2031

Figure 62: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031

Figure 63: Europe Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022

Figure 64: Europe Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 65: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 66: Asia Pacific Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 67: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 68: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031

Figure 69: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022

Figure 70: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031

Figure 71: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031

Figure 72: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022

Figure 73: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023–2031

Figure 74: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031

Figure 75: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022

Figure 76: Asia Pacific Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 77: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 78: Latin America Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 79: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 80: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031

Figure 81: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022

Figure 82: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031

Figure 83: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031

Figure 84: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022

Figure 85: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023–2031

Figure 86: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031

Figure 87: Latin America Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022

Figure 88: Latin America Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 89 Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 90: Middle East & Africa Immunotherapy Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 91: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 92: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022 and 2031

Figure 93: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Drug Type, 2022

Figure 94: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Drug Type, 2023–2031

Figure 95: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022 and 2031

Figure 96: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Therapy Area, 2023–2031

Figure 97: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Therapy Area, 2022

Figure 98: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022 and 2031

Figure 99: Middle East & Africa Immunotherapy Drugs Market Attractiveness Analysis, by Distribution Channel, 2023–2031

Figure 100: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Share Analysis, by Distribution Channel, 2022

List of Tables

List of Tables

Table 01: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031

Table 02: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031

Table 03: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Table 04: Global Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 05: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 06: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031

Table 07: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031

Table 08: North America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Table 09: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 10: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031

Table 11: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031

Table 12: Europe Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Table 13: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 14: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031

Table 15: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031

Table 16: Asia Pacific Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Table 17: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 18: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031

Table 19: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031

Table 20: Latin America Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

Table 21: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 22: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031

Table 23: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Therapy Area, 2017-2031

Table 24: Middle East & Africa Immunotherapy Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031